Ads
related to: biotech- About Us
Discover the Unique Approach
That Makes Genmab Different.
- Sign Up
Sign Up for Updates, News
and Much More.
- Pipeline
Review our Pipeline and
See How We're Changing Treatment.
- Antibody Science
Explore Our Unique Platforms
For Creating Antibody Treatments.
- About Us
Search results
Earnings call: Imunon reports on Q1 2024, optimistic about cancer treatment By Investing.com
Investing.com· 8 hours agoImunon (ticker: IMNN) has announced its financial results and progress in clinical trials for the...
Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building...
WKRN Nashville· 8 hours agoThe Breakthrough Therapy Designation for BRII-877 (tobevibart) was supported by Phase 1 and 2 studies conducted by Vir Biotechnology ("Vir", Nasdaq: VIR) and Brii Bio.
Is Sana Biotechnology (NASDAQ:SANA) In A Good Position To Invest In Growth?
Simply Wall St. via Yahoo Finance· 3 days agoNonetheless, only a fool would ignore the risk that a loss making company burns through its cash too...
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoAdaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2024 Earnings Call Transcript May 7, 2024...
New York Life Investment Management LLC Has $431,000 Stock Holdings in Sana Biotechnology, Inc....
ETF DAILY NEWS· 2 days agoNew York Life Investment Management LLC lessened its position in Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 2.9% during the 4th quarter, according to its most ...
Earnings call: Seres Therapeutics reports on Q1 2024 with VOWST updates By Investing.com
Investing.com· 13 hours agoSeres Therapeutics (NASDAQ:MCRB), a biotechnology firm focused on microbiome therapeutics, has...
Compared to Estimates, Adaptive Biotechnologies (ADPT) Q1 Earnings: A Look at Key Metrics
Zacks via Yahoo Finance· 6 days agoThe headline numbers for Adaptive Biotechnologies (ADPT) give insight into how the company performed...
Why Adaptive Biotechnologies Topped the Market Today
Motley Fool via Yahoo Finance· 5 days agoAdaptive Biotechnologies (NASDAQ: ADPT), a company that, in its own words, "aims to translate the genetics of the adaptive immune system into clinical...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 8 hours agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials
Investing.com· 1 day agoVaxart, Inc. (NASDAQ: NASDAQ: VXRT ), a biotechnology company specializing in the development of...